Novel Factor Oxidized Galectin-1 Advances Functional Recovery after Peripheral Nerve Injury
Novel Factor Oxidized Galectin-1 Advances Functional Recovery after Peripheral Nerve Injury
批准号:
12680758
负责人:
HORIE Hidenori
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
我们发现氧化半乳糖凝集素-1在体外DRG外植体模型和体内周围神经轴突切开术模型中促进横断神经部位的轴突再生。本项目的目的是阐明氧化半乳糖凝集素-1是否促进周围神经损伤后神经功能的恢复。横断成年大鼠坐骨神经,用4根神经外针将远端神经固定于近端。通过渗透泵将氧化半乳糖凝集素-1或对照溶剂外周输送到手术部位。通过测量后爪脚趾伸展程度来评估功能恢复情况。恢复曲线显示氧化半乳糖凝集素-1明显促进功能恢复(与对照组相比,方差分析p<0.05)。组织学研究表明,氧化半乳糖凝集素-1增加了坐骨神经剪断后再生髓鞘轴突的数量。氧化半乳糖凝集素-1给药组有髓鞘轴突直径增大的趋势。这些结果表明,在神经损伤部位给予氧化半乳糖凝集素-1对神经功能的快速恢复是有效的。在此期间,我们已经完成了这个项目的目的,现在正准备发表一篇关于这项工作的论文。
英文摘要
We have revealed that oxidized galectin-1 promotes axonal regeneration from transected-nerve sites in an in vitro DRG explant model as well as in vivo peripheral nerve axotomy models. The purpose of this project is to clarify whether oxidized galectin-1 advances restoration of nerve functions after peripheral nerve injury.The sciatic nerve of an adult rat was transected and then the distal nerve was frozen after sutured into proximal site with four epineurial stitches. Peripheral delivery of oxidized galectin-1 or control solvent to the surgical site was performed with the osmotic pump. The functional recovery was evaluated by measuring the degree of toe spread of the hind paw. The recovery curves indicated that oxidized galectin-1 administration clearly advanced functional recovery (p<0.05 compared with control PBS group by ANOVA). The histological study showed that oxidized galectin-1 increased numbers of regenerating myelinated axons in a sciatic nerve after axotomy. There was the tendency that diameters of the myelinated axons were large in oxidized galectin-1 administrating group. These results indicate that administration of oxidized galectin-1 to the nerve injury sites is effective to the rapid restoration of the nerve function.We have performed the purpose of this project during its period and are now preparing to publish a paper of this work.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nishioka T, Sakumi K, Miura T, Tahara K, Horie H, Kadoya T, and Nakabeppu Y.: "fosB gene products trigger cell proliferation and morphlogical alteration with an increased expression of a novel processed form of galectin-1 in the rat 3Y1 embryo cell line"J
Nishioka T、Sakumi K、Miura T、Tahara K、Horie H、Kadoya T 和 Nakabeppu Y.:“fosB 基因产物通过增加 3Y1 大鼠中新型加工形式的 galectin-1 的表达来触发细胞增殖和形态学改变
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirono M, Sugiyama T. et al.: "phospholipase CB4 and protein Kinase Cx and/or protein Kinase CBI are involed in the induction of long-term depression in cerebellar purkinje cell"J. Biol. Chem.. 276. 45236-45242 (2001)
Hirono M、Sugiyama T. 等人:“磷脂酶 CB4 和蛋白激酶 Cx 和/或蛋白激酶 CBI 参与诱导小脑浦肯野细胞长期抑制”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shuto T, Horie H, Hikawa N, Sango K, Tokashiki A, Murata H, Yamamoto I, and Ishikawa Y.: "IL-6 upregulates CNTF mRNA expression and enhances neurite regeneration"NeuroReport. 12. 1081-1085 (2001)
Shuto T、Horie H、Hikawa N、Sango K、Tokashiki A、Murata H、Yamamoto I 和 Ishikawa Y.:“IL-6 上调 CNTF mRNA 表达并增强神经突再生”NeuroReport。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
NishioKaT, SakumiK et al.: "fosB gene products trigger cell proliferation and morphological alteration with an increased expression of a novel processed form of galectm-1 in the rat3Y lonlnyo cell"J. Biochem.. (in press).
NishioKaT、SakumiK 等人:“fosB 基因产物通过在rat3Y lonlnyo 细胞中增加新型加工形式的 galectm-1 的表达来触发细胞增殖和形态学改变”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirono M, Sugiyama T et al.: "Phospholipase Cβ4 and protein kinase Ca and/or protein kinase CβI are involved in the induction of long term depression in cerebellar purking"J.Boil.Chem.. 276. 45236-45242 (2001)
Hirono M、Sugiyama T 等人:“磷脂酶 Cβ4 和蛋白激酶 Ca 和/或蛋白激酶 CβI 参与诱导小脑 purking 中的长期抑制”J.Boil.Chem.. 276. 45236-45242 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
BASIC RESEARCH FOR EFFECT OF OXIDISED GALECTIN-1 ON PERIODONTAL DISEASE THROUGH MACROPHAGE
-
批准号:20592438
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:HORIE Hidenori
-
依托单位:
A peripheral nerve reproduction control structure by one oxidized form galectin-1 instruction macrophage.
-
批准号:17500265
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:HORIE Hidenori
-
依托单位:
Enhancement of neural regeneration and neural survival in peripheral nervous system by Novel Liver Derived Neuronal Activator
-
批准号:07680849
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1995
-
负责人:HORIE Hidenori
-
依托单位:
Mechanism of new regeneration activating factor of aged nervous tissue secreted from hepatocytes and its determination with vitro immunization
-
批准号:04836020
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1992
-
负责人:HORIE Hidenori
-
依托单位:
Study of changes of neuronal membrane functions with aging by tissue culture method
-
批准号:63570041
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1988
-
负责人:HORIE Hidenori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
-
批准号:82371373
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:沃雁
-
依托单位:
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
-
批准号:82371517
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨立群
-
依托单位:
LIPUS响应的弹性石墨烯多孔导管促进神经再生及其机制研究
-
批准号:82370933
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陆家瑜
-
依托单位:
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
-
批准号:82370921
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:徐袁瑾
-
依托单位:
哺乳动物新生期心肌细胞增殖及其调控机制研究
-
批准号:32100592
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:蒲文娟
-
依托单位:
水稻愈伤组织分化相关蛋白的分离及其功能研究
-
批准号:31201189
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2012
-
负责人:朱克明
-
依托单位:
EphB1-ephrinB2在小鼠视神经轴突再生中的导向作用研究
-
批准号:81170837
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:杨柳
-
依托单位:
骨髓源干细胞参与周围神经再生的实验研究
-
批准号:30973050
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:祁佐良
-
依托单位:
Bcl-2转基因小鼠再生视神经向外侧膝状体的生长导向研究
-
批准号:30872835
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2008
-
负责人:杨柳
-
依托单位: